Today we release Rhaister, an elegant statistical model that predicts drug phenotypes in new contexts w/ accuracies comparable to experimental assays.
And dropping Emerald Bay, a 2M cell dataset measuring long time-course phenotypes across 1000s of drug-cell line interactions.
Great day visiting @phylogenomics and discussing environmental genomics, the tree of life, and the gaps still waiting to be resolved. Excited for collaborations ahead, including with @BioKEAAI.
We are excited to kick of week 2 hosting THE @chr1sa at BioKEA. If you're just joining in, we're adapting the @OpuloInc PnP machine to a biology-purposed bug picker. Today we're unboxing a new Bambu Lab 3D printer and resuming our quest to develop cost-effective biology tools.1/2
All set for day 3 of N collaborating with @chr1sa on the pick and place machine and transforming it into a bug picker. Pushing @OpuloInc tech to solve biology problems!
Two updates I've been sitting on:
1. I'm an Anthropic Claude Community Ambassador for the SF Bay Area 🌊
2. Speaking at Code with Claude next week on why domain experts still matter in the age of AI — drawn from what we're building at @BioKEAAI
https://t.co/X1F87ZbtRa
It was a pleasure meeting members of the @BerkeleyML community last week! Our team always enjoys connecting with talented students who are passionate about ML x Bio 💙
We’re excited to continue these conversations and are open to speaking with prospective internship and full-time candidates. Check out our careers page (link in comments)
We build datasets, train AI models, and use them for the ultimate goal of discovering and developing new medicines, starting from oncology. This joint venture represents another major step towards that and a preview of the business models enabled by our platform.
Alloy and Tahoe are seeding the new company and will co-develop the assets leveraging the biologics capabilities of Alloy coupled with Tahoe's datasets and AI models.
We have talked a lot about the datasets & virtual cell models that we are building @tahoe_ai. Today, we are announcing a joint venture with 82VS, the Venture Studio of Alloy Therapeutics to develop antibody drug conjugates for two novel targets, discovered using our technology.
Over the last year, few institutions have done more for the quest towards virtual cell models than @tahoe_ai, @arcinstitute, and @officialbiohub. Today, in a landmark partnership, we are teaming up to generate the next definitive dataset for virtual cell models, using Tahoe’s Mosaic Technology.
This is first of its kind: multi-million dollar investment from each of these orgs coupled with the massive scale Tahoe’s technology enables. 120M+ cells, 225K unique interactions.
We will build on the gigantic success of Tahoe-100M (downloaded 250K+ times in less than a year), and the lasting impact of Arc’s scBaseCamp, and Biohub’s CELL x GENE, to fuel the next generation of virtual cell models, whether developed by us or others.
It’s morning in biology! Let’s build.
@nalidoust@arcinstitute @officialbiohub Read more about the partnership:
Official Press Release: https://t.co/VPAVnz46Hr
Story by GEN News: https://t.co/bl1ReNsL7K
This is not true! Any phage scientist could tell you that phage are everywhere from sewage, to rivers, to human skin and human gut. Literally everywhere. They are not a barometer of river purity or anything else.
If you're a scientist that serves on an NSF panel that got cancelled today, I'd love to talk to you about it for an NPR story. DM, email or reach out on signal.
PLEASE SHARE! 📢 #CIGLR is excited to announce the opening of our 2025 #GreatLakes Summer Fellow applications! There are 7 full-time, 12-week positions paying $10,000 each. Applications are due 09 Feb 2025 at 11:59 pm EST! Eligibility & how to apply: https://t.co/64i6oFP84m
Check out our last pub. from @mfgrp lab! We discovered that skin commensal microbes induce systemic and local B cell responses upon colonization and took advantage of this knowledge to create topical vaccines using engineered skin microbes. Please read the thread for details.